Black Diamond Therapeutics is a precision oncology medicine company pioneering the discovery of small molecule, tumor-agnostic therapies. Black Diamond targets undrugged mutations in patients with genetically defined cancers.
Market
Precision Oncology
Location
Cambridge,
MA,
USA
Coinvestors
Boxer Capital, BVF Partners, Casdin Capital, Deerfield Management Company, L.P., Invus, Janus Henderson Investors, Logos Capital, New Enterprise Associates, Nextech Invest, RA Capital Management, Versant Ventures, Wellington Management Company